AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2021

Feb 22, 2021

30071_dirs_2021-02-22_25bd4636-40e3-4ce7-8b14-75cc06d66cea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-02-19

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-19	ResMed Common Stock	S	4000	$200.1411	Disposed	18769	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $200.07 to $200.50. The price reported above reflects the weighted average sale price.